Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meal-Time Insulin Dosing Strategies in CFRD
NCT04533646Phase 4Completed
- Start
- Sep 2020
- Primary completion
- Jul 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of human insulin in cystic fibrosis-related diabetes (CFRD). Started Sep 2020; status: completed.
02
Drugs
human insulin
03
Conditions
cystic fibrosis-related diabetes (CFRD)
Beyond the preview
Go deeper on NCT04533646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04533646.